Skip to Main Content


New study shows cost savings to Medicaid due to Direct-Acting Antivirals to treat Hepatitis C

By | Leave a Comment

A recent study indicates that Medicaid is saving money by avoiding other costly health expenses due to people being treated for hepatitis C by direct acting antiviral medications. Read the article here.

Thematic Areas:

Comments are closed.

The views reflected in this expert column are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.